Aspyrian Therapeutics Raise $8.5M

San Diego-based Aspyrian Therapeutics>, which is developing technology to treat cancer tumors, has raised nearly $8.5M in a funding round, according to a regulatory filing. Details and investors in the company were not announced. Aspyrian is commercializing technology originally developed at the National Center Insitute, aimed at selective, surgical removal of cancer tumor cells. More information »